Omega Fund V Gp, L.p. - Net Worth and Insider Trading
Omega Fund V Gp, L.p. Net Worth
The estimated net worth of Omega Fund V Gp, L.p. is at least $306 Million dollars as of 2024-11-05. Omega Fund V Gp, L.p. is the 10% Owner of Nuvation Bio Inc and owns about 23,457,340 shares of Nuvation Bio Inc (NUVB) stock worth over $127 Million. Omega Fund V Gp, L.p. is the Director of Morphic Holding Inc and owns about 2,086,071 shares of Morphic Holding Inc (MORF) stock worth over $119 Million. Omega Fund V Gp, L.p. is also the 10% Owner of Nuvation Bio Inc and owns about 20,457,340 shares of Nuvation Bio Inc (NUVB) stock worth over $47 Million. Besides these, Omega Fund V Gp, L.p. also holds Gossamer Bio Inc (GOSS) , Kronos Bio Inc (KRON) , Trevi Therapeutics Inc (TRVI) . Details can be seen in Omega Fund V Gp, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Omega Fund V Gp, L.p. has not made any transactions after 2022-04-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Omega Fund V Gp, L.p.
Omega Fund V Gp, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Omega Fund V Gp, L.p. owns 7 companies in total, including Kronos Bio Inc (KRON) , Gossamer Bio Inc (GOSS) , and Morphic Holding Inc (MORF) among others .
Click here to see the complete history of Omega Fund V Gp, L.p.’s form 4 insider trades.
Insider Ownership Summary of Omega Fund V Gp, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KRON | Kronos Bio Inc | 2020-10-14 | 10 percent owner |
| GOSS | Gossamer Bio Inc | 2019-09-20 | 10 percent owner |
| MORF | Morphic Holding Inc | 2021-04-28 | director |
 | | 2019-05-09 | 10 percent owner |
| | 2019-04-12 | 10 percent owner |
| | 2018-07-02 | 10 percent owner |
| | 2022-04-05 | 10 percent owner |
Omega Fund V Gp, L.p. Latest Holdings Summary
Omega Fund V Gp, L.p. currently owns a total of 6 stocks. Among these stocks, Omega Fund V Gp, L.p. owns 23,457,340 shares of Nuvation Bio Inc (NUVB) as of December 7, 2021, with a value of $127 Million and a weighting of 41.61%. Omega Fund V Gp, L.p. owns 2,086,071 shares of Morphic Holding Inc (MORF) as of April 28, 2021, with a value of $119 Million and a weighting of 38.8%. Omega Fund V Gp, L.p. also owns 20,457,340 shares of Nuvation Bio Inc (NUVB) as of April 5, 2022, with a value of $47 Million and a weighting of 15.49%. The other 3 stocks Gossamer Bio Inc (GOSS) , Kronos Bio Inc (KRON) , Trevi Therapeutics Inc (TRVI) have a combined weighting of 4.11% among all his current holdings.
Latest Holdings of Omega Fund V Gp, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NUVB | Nuvation Bio Inc | 2021-12-07 | 23,457,340 | 5.44 | 127,490,643 |
| MORF | Morphic Holding Inc | 2021-04-28 | 2,086,071 | 56.99 | 118,885,186 |
| NUVB | Nuvation Bio Inc | 2022-04-05 | 20,457,340 | 2.32 | 47,461,029 |
| GOSS | Gossamer Bio Inc | 2019-09-20 | 6,553,416 | 0.88 | 5,750,623 |
| KRON | Kronos Bio Inc | 2020-10-14 | 3,818,283 | 0.95 | 3,627,369 |
| TRVI | Trevi Therapeutics Inc | 2019-05-09 | 1,063,408 | 3.02 | 3,211,492 |
Holding Weightings of Omega Fund V Gp, L.p.
Omega Fund V Gp, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Omega Fund V Gp, L.p. has made a total of 4 transactions in Nuvation Bio Inc (NUVB) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Nuvation Bio Inc is the sale of 1,400,000 shares on December 7, 2021, which brought Omega Fund V Gp, L.p. around $14 Million.
According to the SEC Form 4 filings, Omega Fund V Gp, L.p. has made a total of 38 transactions in Morphic Holding Inc (MORF) over the past 5 years, including 0 buys and 38 sells. The most-recent trade in Morphic Holding Inc is the sale of 10,704 shares on April 28, 2021, which brought Omega Fund V Gp, L.p. around $593,216.
According to the SEC Form 4 filings, Omega Fund V Gp, L.p. has made a total of 1 transactions in Nuvation Bio Inc (NUVB) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Nuvation Bio Inc is the sale of 2,500,000 shares on April 5, 2022, which brought Omega Fund V Gp, L.p. around $14 Million.
More details on Omega Fund V Gp, L.p.'s insider transactions can be found in the Insider Trading History of Omega Fund V Gp, L.p. table.Insider Trading History of Omega Fund V Gp, L.p.
- 1
Omega Fund V Gp, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Omega Fund V Gp, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Omega Fund V Gp, L.p. is -19.89%. GuruFocus also compares Omega Fund V Gp, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Omega Fund V Gp, L.p. within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Omega Fund V Gp, L.p.'s insider trading performs compared to the benchmark.
Performance of Omega Fund V Gp, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.39 | | | | | |
| Relative Return to S&P 500(%) | -0.44 | | | | | |
Omega Fund V Gp, L.p. Ownership Network
Ownership Network List of Omega Fund V Gp, L.p.
Ownership Network Relation of Omega Fund V Gp, L.p.
Omega Fund V Gp, L.p. Owned Company Details
What does Kronos Bio Inc do?
Who are the key executives at Kronos Bio Inc?
Omega Fund V Gp, L.p. is the 10 percent owner of Kronos Bio Inc. Other key executives at Kronos Bio Inc include director & 10 percent owner & President & CEO Norbert W Bischofberger , COO & General Counsel Barbara Kosacz , and Chief Scientific Officer Christopher Dinsmore .
Kronos Bio Inc (KRON) Insider Trades Summary
Over the past 18 months, Omega Fund V Gp, L.p. made no insider transaction in Kronos Bio Inc (KRON). Other recent insider transactions involving Kronos Bio Inc (KRON) include a net purchase of 5,351,696 shares made by Norbert W Bischofberger , a net sale of 40,194 shares made by Jorge Dimartino , and a net sale of 24,032 shares made by Christopher Dinsmore .
In summary, during the past 3 months, insiders sold 0 shares of Kronos Bio Inc (KRON) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,028 shares of Kronos Bio Inc (KRON) were sold and 5,351,696 shares were bought by its insiders, resulting in a net purchase of 5,235,668 shares.
Kronos Bio Inc (KRON)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kronos Bio Inc Insider Transactions
Omega Fund V Gp, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Omega Fund V Gp, L.p.. You might contact Omega Fund V Gp, L.p. via mailing address: 888 Boylston St., Suite 1111, Boston Ma 02199.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
